Transcend Medical Submits Final Module of FDA Premarket Approval Application for the CyPass(R) Glaucoma Micro-Stent
MENLO PARK, CA--(Marketwired - October 22, 2015) - Transcend Medical, Inc., a pioneer of minimally invasive glaucoma surgery (MIGS), today announced the submission to the U.S. Food and Drug Administration (FDA) of the final module of the company's …